Affinity Asset Advisors, LLC XENE Holdings History
Affinity Asset Advisors, LLC's Xenon Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Affinity Asset Advisors, LLC held 1.33 Mil shares of Xenon Pharmaceuticals Inc(XENE), totaling $44.56 Mil. This investment constitutes 4.39% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 1.73% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.
The initial trade took place in 2021Q3. And since then Affinity Asset Advisors, LLC has made 11 purchases of XENE, at an average price of $38.80, for a total of 1.51 Mil shares. In addition, there have been 3 sales at an average price of $31.70 for 180,124.00 shares. Based on historical transaction data and XENE's current price of $31.83, Affinity Asset Advisors, LLC's estimated gain on his XENE holdings is $-10.54 Mil, reflecting a -18.01% gain to date.
Affinity Asset Advisors, LLC XENE ($31.83) Holding Chart
Affinity Asset Advisors, LLC XENE ($31.83) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1